| [1] |
孙万, 王洁雨, 邓雪英. 导管导向CT血管造影用于钇-90(90Y)微球选择性内放射治疗肝脏恶性肿瘤进展[J]. 中国介入影像与治疗学, 2025, 22(2):146-149.
|
| [2] |
高洁, 刘晓明, 周文华, 等. 90Y微球的研发现状与应用研究[J]. 同位素, 2022, 35(3):189-199.
|
| [3] |
WEBER M, LAM M, CHIESA C, et al. EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds[J]. Eur J Nucl Med Mol Imaging, 2022, 49(5):1682-1699.
DOI
|
| [4] |
宋莉, 邹英华. 钇-90微球管理专家共识[J]. 中国介入影像与治疗学, 2021, 18(6):321-325.
|
| [5] |
BROWN A M, KASSAB I, MASSANI M, et al. TACE versus TARE for patients with hepatocellular carcinoma:Overall and individual patient level meta analysis[J]. Cancer Med, 2023, 12(3):2590-2599.
DOI
URL
|
| [6] |
VILLALOBOS A, SOLIMAN M M, MAJDALANY B S, et al. Yttrium-90 radioembolization dosimetry:What trainees need to know[J]. Semin Intervent Rad, 2020, 37(5):543-554.
|
| [7] |
LEE E W, AlLANIS L, CHO S K, et al. Yttrium-90 selective internal radiation therapy with glass microspheres for hepatocellular carcinoma:Current and updated literature review[J]. Korean J Radiol, 2016, 17(4):472-488.
DOI
URL
|
| [8] |
LAU W Y, LAI E C, LEUNG T W. Current role of selective internal irradiation with yttrium-90 microspheres in the management of hepatocellular carcinoma:A systematic review[J]. Interna J Rad Onco Bio Hhy, 2011, 81(2):460-467.
|
| [9] |
COMMANDER C W, MAURO D M. Current approach to planning angiography and MAA administration[J]. Semin Intervent Rad, 2021, 38(4):397-404.
DOI
PMID
|
| [10] |
LAFFONT S, ROLLAND Y, ARDISSON V, et al. Occupational radiation exposure of medical staff performing 90Y-loaded microsphere radioembolization[J]. Eur J Nucl Med Mol Imaging, 2016, 43(5):824-831.
DOI
URL
|
| [11] |
SHIM J, KIM G M, KIM D Y, et al. Measuring radiation exposure of operators engaged in the Yttrium-90 microsphere radioembolization treatment of hepatocellular carcinoma patients[J]. Optik, 2021,243:167392.
|
| [12] |
SCOTOGNELLA T, MORASCA A, ZAGARIA L, et al. Radiation exposure of the operators in the preparation and administration of Yttrium-90 microspheres in the treatment of malignant hepatic lesions:What is the risk?[J]. Rev Esp Med Nucl Imagen Mol, 2021, 40(5):293-298.
|
| [13] |
GATES V L, GABR A, KALLINI J, et al. Commentary on:“Occupational radiation exposure of medical staff performing 90Y-loaded microsphere radioembolization”[J]. Eur J Nucl Med Mol Imaging, 2016, 43(5):822-823.
DOI
URL
|
| [14] |
ANDREW C G. Tuning your RADIO embolization:Imaging-guidance of Yttrium-90 radioembolization[M]. Evanston: Pro Quest LLC, 2016:51-58.
|
| [15] |
PARK S, KIM M, KIM J H. Radiation safety for pain physicians:Principles and recommendations[J]. Korean J Pain, 2022, 35(2):129-139.
DOI
URL
|
| [16] |
DECOTEAU M A, STEUTERMAN S, KURIAN S M, et al. Mitigation of radiation exposure during surgical hepatectomy after Yttrium-90 radioembolization[J]. J Radio Prot, 2021, 41(3):N1-N11.
|
| [17] |
耿建华, 陈英茂, 王晓涛, 等. 钇[90Y]树脂微球介入治疗的放射防护评估[J]. 中国辐射卫生, 2021, 30(6):720-726.
|
| [18] |
贠彦祺, 周艳芝, 张彦炀. 关于钇-90树脂微球核素治疗中的辐射防护研究[J]. 核安全, 2023, 22(4):1-6.
|
| [19] |
林怀英, 王战勇, 邓飞, 等. 广东省部分钇-90树脂微球治疗场所辐射水平调查[J]. 中国辐射卫生, 2024, 33(5):517-522.
|
| [20] |
范向勇, 陈维, 曹兴江, 等. 钇-90微球选择性内放射治疗放射防护检测与防护措施建议[J]. 中国职业医学, 2025, 52(2):193-197.
|
| [21] |
国家卫生健康委员会. 医用X射线诊断设备质量控制检测规范:WS 76—2020[S]. 北京: 中国标准出版社, 2020.
|
| [22] |
赵三虎, 吴寿明, 赵尧贤, 等. 浙江省部分介入放射工作场所防护现状及辐射水平调查[J]. 中华放射医学与防护杂志, 2017, 37(8):605-608.
|
| [23] |
SALEM R, PADIA S A, LAM M, et al. Clinical,dosimetric,and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma:Updated 2022 recommendations from an international multidisciplinary working group[J]. Eur J Nucl Med Mol Imaging, 2023, 50(2):328-343.
DOI
|
| [24] |
黄晓倩, 侯周森. 钇-90树脂微球治疗项目放射防护评价[J]. 职业与健康, 2024, 40(7):889-892.
|
| [25] |
李宝欣, 李亚京, 于磊, 等. 北京地区介入放射诊疗资源与防护状况调查与分析[J]. 中华放射医学与防护杂志, 2022, 42(7):531-537.
|
| [26] |
姜雯雯, 崔力萌, 丁库克, 等. 介入放射工作人员受照剂量监测及健康风险研究现状[J]. 职业与健康, 2025, 41(12):1707-1713.
|
| [27] |
练德幸, 寇珊珊, 陆见霏, 等. 90Y树脂微球选择性内放射治疗放射防护检测与剂量评估[J]. 中华放射医学与防护杂志, 2022, 42(5):385-390.
|